Why the study?
The study evaluated the efficacy and side effects of antiarrhythmic pharmacotherapies in managing tachyarrhythmia episodes in pediatric patients with congenital heart diseases post-tricuspid valve repair.
Does antiarrhythmic pharmacotherapy with amiodarone, propranolol, or their combination improve arrhythmia responsiveness in pediatric patients following cardiac surgery?
Does antiarrhythmic pharmacotherapy with amiodarone, propranolol, or their combination improve arrhythmia responsiveness in pediatric patients following cardiac surgery?
Amiodarone, propranolol, and their combination demonstrate comparable efficacy and safety in managing postoperative arrhythmias in pediatric patients undergoing tricuspid valve repair.
May guide antiarrhythmic selection post-pediatric tricuspid repair; leaves open need for RCTs to confirm efficacy and safety.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Almomani et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: